Affiliation:
1. Federal Research Center «Krasnoyarsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences», Research Institute of Medical Problems of the North
2. Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of Russia
Abstract
A review of information about musculoskeletal pain in adolescents is presented: the causes of their development, prevalence, classification, clinical manifestations, treatment and prevention. Included are the results of our own research, which showed the peculiarities of the relationship between the frequency of occurrence and the structure of these types of pathology in adolescents with different variants of the course of recurrent cephalalgia – episodic (rare) and chronic (frequent). Frequent dorsalgia in adolescents is significantly more often associated with chronic cephalgia (32.0%), and rare ones – with episodic (46.9%). Girls have a higher incidence of frequent dorsalgia associated with chronic (37.1 and 14.3%) and episodic (22.2 and 16.4%) cephalgia. The authors come to the conclusion about the need for early diagnosis, prevention and timely treatment of dorsalgia associated in adolescents with chronic and episodic cephalgia, and highlight approaches to the treatment and prevention of musculoskeletal pain in children and adolescents.
Publisher
Russian Vrach, Publishing House Ltd.
Reference50 articles.
1. Бочанова Е.Н., Гацких И.В., Потупчик Т.В. и др. Сравнительный анализ поливитаминов для детей. Вопросы биологической, медицинской и фармацевтической химии. 2020; 23 (11): 10–5 [Bochanova E.N., Gatskikh I.V., Potupchik T.V. et al. Comparative analysis of multivitamins for children. Problems of biological, medical and pharmaceutical chemistry. 2020; 23 (11): 10–5 (in Russ.)]. DOI: 10.29296/25877313-2020-11-02
2. Воробьева О.В. Хронические болевые синдромы в клинике нервных болезней: вопросы долговременной аналгезии. Consilium Medicum. 2006; 8 (8): 55–60 [Vorobyeva O.V. Chronic pain syndromes in the clinic of nervous diseases: issues of long-term analgesia. Consilium Medicum. 2006; 8 (8): 55–60 (in Russ.)].
3. Годзенко А.А., Бадокин В.В. Локальная терапия миофасциального болевого синдрома. РМЖ. Ревматология. 2007; 26: 1998–2003 [Godzenko A.A., Badokin V.V. Local therapy of myofascial pain syndrome. RMJ. Rheumatology. 2007; 26: 1998–2003 (in Russ.)].
4. Голованова В.А., Парфенов В.А. Лечение скелетно-мышечных болей в период пандемии COVID-19. Клиническая фармакология и терапия. 2022; 31 (1): 24–31 [Golovanova V.A., Parfenov V.A. Treatment of musculoskeletal pain during COVID-19 pandemics. Clinical pharmacology and therapy. 2022; 31 (1): 24–31(in Russ.)]. DOI: 10.32756/0869-5490-2022-1-24-31
5. Государственный реестр лекарственных средств [Электронный ресурс] [State Register of medicinal products [Electronic resource] (in Russ.)]. URL: https://grls.rosminzdrav.ru/